Literature DB >> 31898441

Relationships between blood leukocyte mitochondrial DNA copy number and inflammatory cytokines in knee osteoarthritis.

Dong Zhan1,2, Aree Tanavalee3, Saran Tantavisut3, Srihatach Ngarmukos3, Steven W Edwards4, Sittisak Honsawek2,3.   

Abstract

Osteoarthritis (OA) is a degenerative articular disorder manifested by cartilage destruction, subchondral sclerosis, osteophytes, and synovitis, resulting in chronic joint pain and physical disability in the elderly. The purpose of this study was to investigate mitochondrial DNA copy number (mtDNACN) and inflammatory cytokines in primary knee OA patients and healthy volunteers. A total of 204 knee OA patients and 169 age-matched healthy volunteers were recruited. Their relative blood leukocyte mtDNACN was assessed by quantitative real-time polymerase chain reaction (qRT-PCR), and ten inflammatory cytokines in their plasma were detected by multiplex immunoassay. Blood leukocyte mtDNACN in the OA group was significantly lower than that in the control group. Leukocyte mtDNACN in the control group was negatively correlated with their age (r=-0.380, P<0.0001), whereas mtDNACN in the OA group was positively correlated with their age (r=0.198, P<0.001). Plasma interleukin-4 (IL-4) and IL-6 were significantly higher in the knee OA group than in the control group. The plasma IL-6 level was positively correlated with blood leukocyte mtDNACN in the OA group (r=0.547, P=0.0014). IL-5 showed as a major factor (coefficient 0.69) in the second dimension of principle components analysis (PCA)-transformed data and was significantly higher in the OA group (P<0.001) as well as negatively correlated with mtDNACN (r=-0.577, P<0.001). These findings suggest that elevation of plasma IL-4 and IL-6 and a relative reduction in mtDNACN might be effective biomarkers for knee OA. IL-5 is a plausible factor responsible for decreasing blood leukocyte mtDNACN in knee OA patients.

Entities:  

Keywords:  Inflammatory cytokine; Blood leukocyte; Knee; Mitochondrial DNA copy number; Osteoarthritis

Mesh:

Substances:

Year:  2020        PMID: 31898441      PMCID: PMC6964998          DOI: 10.1631/jzus.B1900352

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  34 in total

1.  Correlation of CD₄⁺ CD₂₅⁺ Foxp₃⁺ Treg with the recovery of joint function after total knee replacement in rats with osteoarthritis.

Authors:  S-Y Guo; Y-J Ding; L Li; T Zhang; Z-Z Zhang; E-S Zhang
Journal:  Genet Mol Res       Date:  2015-07-03

2.  Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.

Authors:  M D Smith; S Triantafillou; A Parker; P P Youssef; M Coleman
Journal:  J Rheumatol       Date:  1997-02       Impact factor: 4.666

3.  Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis.

Authors:  S Kaneko; T Satoh; J Chiba; C Ju; K Inoue; J Kagawa
Journal:  Cytokines Cell Mol Ther       Date:  2000-06

4.  Elevated serum levels of soluble interleukin-4 receptor in osteoarthritis.

Authors:  T Silvestri; L Pulsatelli; P Dolzani; A Facchini; R Meliconi
Journal:  Osteoarthritis Cartilage       Date:  2006-04-27       Impact factor: 6.576

5.  Oxyresveratrol ameliorates allergic airway inflammation via attenuation of IL-4, IL-5, and IL-13 expression levels.

Authors:  Muhammad Imran Ashraf; Muhammad Shahzad; Arham Shabbir
Journal:  Cytokine       Date:  2015-10-01       Impact factor: 3.861

6.  Serum cytokines are increased and circulating micronutrients are not altered in subjects with early compared to advanced knee osteoarthritis.

Authors:  Tyler Barker; Victoria E Rogers; Vanessa T Henriksen; Dale Aguirre; Roy H Trawick; G Lynn Rasmussen; Nathan G Momberger
Journal:  Cytokine       Date:  2014-04-29       Impact factor: 3.861

7.  Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study.

Authors:  Gregory Livshits; Guangju Zhai; Deborah J Hart; Bernet S Kato; Huizhong Wang; Frances M K Williams; Tim D Spector
Journal:  Arthritis Rheum       Date:  2009-07

8.  Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense.

Authors:  Shida Yousefi; Jeffrey A Gold; Nicola Andina; James J Lee; Ann M Kelly; Evelyne Kozlowski; Inès Schmid; Alex Straumann; Janine Reichenbach; Gerald J Gleich; Hans-Uwe Simon
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

Review 9.  Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target.

Authors:  Alain Meyer; Joffrey Zoll; Anne Laure Charles; Anne Charloux; Frédéric de Blay; Pierre Diemunsch; Jean Sibilia; François Piquard; Bernard Geny
Journal:  Exp Physiol       Date:  2013-02-01       Impact factor: 2.969

10.  Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease.

Authors:  Shih-Feng Liu; Ho-Chang Kuo; Ching-Wan Tseng; Hung-Tu Huang; Yung-Che Chen; Chia-Cheng Tseng; Meng-Chih Lin
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

View more
  4 in total

1.  Leukocyte mitochondrial DNA copy number is a potential non-invasive biomarker for psoriasis.

Authors:  Materah Salem Alwehaidah; Suad AlFadhli; Ghada Al-Kafaji
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

2.  Mitochondrial Displacement Loop Region SNPs Modify Sjögren's Syndrome Development by Regulating Cytokines Expression in Female Patients.

Authors:  Yufei Zhao; Chenxing Peng; Jingjing Zhang; Ruixue Lai; Xiaoyun Zhang; Zhanjun Guo
Journal:  Front Genet       Date:  2022-03-11       Impact factor: 4.599

3.  The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis.

Authors:  Yufei Zhao; Chenxing Peng; Ruixue Lai; Jingjing Zhang; Xiaoyun Zhang; Zhanjun Guo
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

Review 4.  Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging.

Authors:  Debmita Chatterjee; Palamou Das; Oishee Chakrabarti
Journal:  Front Cell Dev Biol       Date:  2022-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.